Lexeo Therapeutics (LXEO) Q4 2023 Earnings

11MarConfirmed
Q4 2023
-0.86
-0.81
-0.75
-0.7

Details

Expected EPS
-0.696745
Actual EPS
-0.86
Surprise EPS
-0.16
Surprise Percent
+23.43%

Description

Lexeo Therapeutics (LXEO) has reported earnings of -0.86 per share for Q4 2023.

0 Comments

Share your thoughts